Xerese (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Xerese drug offered from Valeant Pharmaceuticals North America LLC. This DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
NON-PROPRIETARY NAME: | Acyclovir and Hydrocortisone |
SUBSTANCE NAME: | ACYCLOVIR; HYDROCORTISONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-07-31 |
END MARKETING DATE: | 0000-00-00 |
Xerese HUMAN PRESCRIPTION DRUG Details:
Item Description | Xerese from Valeant Pharmaceuticals North America LLC |
LABELER NAME: | Valeant Pharmaceuticals North America LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50; 10(mg/g; mg/g) |
START MARKETING DATE: | 2009-07-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0187-5104_55989c60-a53f-45fe-a543-894782c85f91 |
PRODUCT NDC: | 0187-5104 |
APPLICATION NUMBER: | NDA022436 |
Other ACYCLOVIR; HYDROCORTISONE Pharmaceutical Manufacturers / Labelers: